ReviewJournal of immunology research2026
Role of Scar-Associated Macrophages in Organ Fibrosis Diseases.
Review in Journal of immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- mRNA-laden LNP-enabled in situ CAR-macrophage alleviates liver fibrosis via inhibiting activated HSCs and modulating the immune microenvironment.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Role of Scar-Associated Macrophages in Organ Fibrosis Diseases.Journal of immunology research · 2026Review
- Integrating mechanical cues inFrontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Fibrosis refers to the scarring and hardening of tissue resulting from the excessive deposition of extracellular matrix (ECM) proteins by myofibroblasts during chronic inflammatory responses, which can ultimately lead to organ failure and potentially death. Different states of macrophage activation are critical in regulating both the progression and regression of fibrosis. However, the conventional M1/M2 polarization model fails to accurately capture the dynamic and heterogeneous states of macrophages observed in vivo. As a result, an increasing number of studies have begun to classify macrophages based on their functional phenotypes. One specific subset of functionally distinct macrophages, termed scar-associated macrophages (SAMs), has been confirmed to play a significant regulatory role in organ fibrosis. This review provides a comprehensive summary of recent advances in understanding the role of SAMs in fibrotic diseases across multiple organs, including the liver, lungs, heart, and kidneys. It further explores the emerging conceptual framework of hot and cold fibrosis, highlighting the potential role of SAMs as central cellular mediators that sustain a positive feedback loop between inflammation and fibrosis in the "hot fibrosis" state. Building on these insights, this review also discusses future research directions aimed at developing targeted therapeutic strategies to modulate SAM activity and mitigate fibrosis in diverse organ systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.